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Abstract
Niemann-Pick C disease (NPC) is an autosomal recessive lysosomal storage disorder characterized by accumulation of
unesterified cholesterol and other lipids within the lysosomes due to mutation in NPC1 or NPC2 genes. A feline model of
NPC carrying a mutation in NPC1 gene has been previously described. We have identified two kittens affected by NPC
disease due to a mutation in NPC2 gene. They manifested with tremors at the age of 3 months, which progressed to
dystonia and severe ataxia. At 6 months of age cat 2 was unable to stand without assistance and had bilaterally reduced
menace response. It died at the age of 10 months. Post-mortem histological analysis of the brain showed the presence of
neurons with cytoplasmic swelling and vacuoles, gliosis of the substantia nigra and degeneration of the white matter.
Spheroids with accumulation of ubiquitinated aggregates were prominent in the cerebellar cortex. Purkinje cells were
markedly reduced in number and they showed prominent intracytoplasmic storage. Scattered perivascular aggregates of
lymphocytes and microglial cells proliferation were present in the thalamus and midbrain. Proliferation of Bergmann glia
was also observed. In the liver, hepatocytes were swollen because of accumulation of small vacuoles and foamy Kupffer cells
were also detected. Foamy macrophages were observed within the pulmonary interstitium and alveoli as well. At 9 months
cat 1 was unable to walk, developed seizures and it was euthanized at 21 months. Filipin staining of cultured fibroblasts
showed massive storage of unesterified cholesterol. Molecular analysis of NPC1 and NPC2 genes showed the presence of a
homozygous intronic mutation (c.82+5G.A) in the NPC2 gene. The subsequent analysis of the mRNA showed that the
mutation causes the retention of 105 bp in the mature mRNA, which leads to the in frame insertion of 35 amino acids
between residues 28 and 29 of NPC2 protein (p.G28_S29ins35).
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Introduction
Niemann Pick C [NPC-MIM 257220; MIM607625] disease is a
neurodegenerative lysosomal storage disorder due to mutations in
NPC1 or NPC2 genes. Both NPC1 and NPC2 proteins are
involved in the intracellular trafficking of cholesterol and other
lipids. Thus, the deficiency of either of them leads to the
accumulation of the endocytosed unesterified cholesterol, gangli-
osides and other lipids within the lysosome/late endosome
compartment [1].
Approximately 95% of NPC patients present mutations in
NPC1 gene (MIM 607623; chr 18q11–q12) [2], [3], which
encodes a membrane glycoprotein of 1,278 amino acids contain-
ing 13 transmembrane domains and localized in late endosomes.
The other 5% of patients present mutations in NPC2 gene (MIM
601015; chr 14q24.3) [4] encoding a soluble 151 amino acid
protein that is present in the lumen of lysosomes.
In humans, NPC disease presents a highly variable phenotype
ranging from fetal to adult age. Apart from patients affected by the
perinatal form of the disease, which manifests at birth or within the
first month of life with severe visceral involvement (fetal hydrops,
ascites, neonatal cholestasis, liver failure and/or specific pulmo-
nary disease), often leading to death [5], [6], most patients develop
a progressive and fatal neurological disease. In these patients, even
if initial manifestations may be systemic, with liver and spleen
enlargement, neurological, or psychiatric, the disease has been
classified according to the age at onset of neurological symptoms in
a severe infantile form (onset before 2 y of age), a late infantile
form (onset between 3–5 y of age), a juvenile form (onset between
5 and 16 y) and an adult form (onset at age.16 y) [1], [7].
Patients with mutations in NPC1 or NPC2 are almost identical
from the clinical point of view. However a high incidence of severe
respiratory insufficiency has been reported in infants having
mutations in the NPC2 gene [8]. Furthermore, in two patients’
lung lavage, radiology and histology showed signs of pulmonary
alveolar lipoproteinosis [9], [10].
Two mouse models of NPC1 and one of NPC2 disease have
been described. Both mouse models of NPC1 recapitulate the
main features of human pathology. However, while the naturally
occurring NPC1 mouse (BALB\c NPC) presents a very severe
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phenotype [11], the Npc1 (nmf164) mouse, which carries the
c.3163A.G mutation, displays a slower development of the NPC
phenotype [12].
The phenotype of the transgenic NPC2 hypomorph mouse, and
the BALB\c NPC are very similar albeit with slightly later onset
and slower progression [13].
In addition, a canine and a feline NPC1 models, both
spontaneous, are known [14], [15]. In particular, the feline model,
which presents a missense mutation c.2864G.C (C955S) [15], has
been exhaustively characterized and is phenotypically, morpho-
logically, and biochemically similar to human juvenile neurolog-
ical form of NPC [16].
In this study we describe two kittens (one male and one female)
from the same litter affected by NPC disease caused by a mutation
in the NPC2 gene.
Materials and Methods
All interventions were performed as part of routine monitoring
and care. Skin biopsy and post-mortem tissues of affected kittens
were obtained in the course of diagnostic work-up while skin tissue
from a healthy cat was obtained during surgical sterilization.
The cat euthanized (cat1) was pre anesthetized with dexmede-
tomidine (40 ug/kg), then a deep plane of general anesthesia was
induced with propofol. An intravenous infusion of a solution of
Embutramide, Mebezonium iodide and Tetracaine hydrochloride
(Tanax - Intervet Italia) was performed following the doses
indicated by the manufacturer.
The local ethics committee was notified and because it controls
animal experimentation and not non-experimental clinical veter-
inary practices (Dlgs N.26 4/3/2014), the committee waived
approval.
All the procedures were performed in agreement with FVE
code of good veterinary practice (http://www.fve.org/news/
publications/pdf/gvp.pdf). In all cases written consent was
obtained from animal’s owners.
Cell culture and filipin staining
Fibroblasts from an affected cat and a normal control were
obtained from skin biopsies. Briefly, skin tissues were washed three
times in PBS containing antibiotics and then three times with
Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen, Grand
Island, NY, USA) supplemented with 10% foetal bovine serum
(FBS; Invitrogen) and antibiotics.
After washing, the samples were placed in 60-mm culture dishes
containing DMEM supplemented with 10% FBS and antibiotics
and cultured at 37uC in a humidified atmosphere containing 5%
Table 1. Laboratory parameters.
5 months 7 months 19 months Reference values
RBC 10‘6 ml 8.19 9.17 8.61 5.0–10.0
WBC 10‘3 ml 14.3 11.4 16.4 6.0–17.0
Hgb g/dl 11.8 12.7 13.0 9–15
Hct % 31.3 34.5 38.4 30–45
MCV fl 38.2 37.6 44.6 40–54
RDW % 22.4 21.8 22.0 14–18
MCHC g/dl 37.7 36.7 34.0 31–36
MCH pg 14.4 13.8 15.1 14–18
PLT 10‘3 ml 448 554 260 250–750
Total Bilirubin mg/dl 0.11 0.01 0.05 0.01–0.2
Fasting Bile acids mmol/L 3.99 ,10
ALT U/l 51 102 42 5–45
GGT U/l 0.1 0.2 0.1 0.1–5
Glucose mg/dl 81 70 93 60–130
BUN mg/dl 48.5 45 37.3 20–65
Creatinine mg/dl 0.53 0.65 0.45 0.1–1.6
ALP U/l 73 48 19 10–100
Total Protein g/dl 6.23 6.33 6.95 6.5–8.5
Albumin g/dl 3.11 3.26 3.31 2.3–3.3
Total Cholesterol mg/dl 81 120 75–150
Triglycerides mg/dl 33 72 50–100
Total Ca mg/dl 9.98 8–12
Ph mg/dl 7.36 3–5
Na mEq/l 149.9 145–158
Cl mEq/l 115.7 110–130
K mEq/l 3.78 3–4.8
CK U/l 123 10–100
LDH U/l 50 10–150
doi:10.1371/journal.pone.0112503.t001
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CO2. The culture medium was changed every 2 days. When cells
reached 90% confluence were trypsinized and seeded into 6 well
plates or on coverslips, or frozen at 280uC using a Mr Frosty
(Sigma) device gradient and stored in liquid nitrogen.
Filipin staining was performed using the method described by
Blanchette-Mackie et al [17].
Mutational analysis
Genomic DNA and total RNA were extracted from cultured
fibroblasts using QIAamp DNA blood Mini Kit (Qiagen GmbH,
Hilden, Germany) and Rneasy mini Kit (Qiagen GmbH, Hilden,
Germany), respectively.
The exonic and the flanking intronic sequences of the feline
NPC1 and NPC2 genes (NC_018734.1 and NC_018728.1,
respectively) were PCR amplified using specific primers. PCR
primers designed using the Primer3 program, and PCR conditions
are available upon request.
For RT-PCR analysis of the NPC2 mRNA the first strand
cDNA was synthesized using random hexamer primers and
subsequent amplified using primers located in the 59UTR and
39UTR region.
PCR and RT-PCR products were analyzed by automated
sequencing (ABI Prism 3500xl genetic analyzer). Putative muta-
tions were confirmed by sequencing duplicate PCR products and
by the DNA analysis from the mother.
Western bot
Twenty micrograms of protein extracts were resolved on 15%
SDS PAGE gels and transferred to nitrocellulose membranes
(Schleicher and Schuell, Keene, NH, USA). After overnight
blocking with 5% nonfat dry milk in PBS-Tween 0.1% (PBS-T),
the membranes were probed with anti-NPC2 polyclonal antibody
(Sigma, St Louis, MO, USA) overnight at 4uC. Anti-rabbit HPR
conjugated antibody was used as a secondary antibody. Immuno-
reactive bands were detected by enhanced chemiluminescence
ECL (Amersham). The signals were normalized to those obtained
for actin using a polyclonal anti-actin antibody (Sigma, St Louis,
MO, USA).
Structural 3D analysis
A multiple sequence alignment of NPC2 homologs was made
using Clustal-Omega [18]. The amino acid sequences of wild type
and mutant NPC2 protein were used to predict the interactions
due to disulfide bonds through the DiANNA website (http://
clavius.bc.edu/,clotelab/DiANNA/). The image of the bovine
NPC2 (bNPC2) crystal structure, as well as the identification of
amino acid residues, was done using the SWISS-PDB VIEWER
(http://www.expasy.org/spdbv/; [19]).
Histology
The brain and spinal cord and samples of major organs were
fixed in phosphate buffered 4% formalin solution. Tissue samples
Figure 1. Biochemical and molecular studies. A) Filipin staining of intracellular unesterified cholesterol in cat cultured fibroblasts. B) Upper
panel: schematic representation of the 59region of NPC2 gene. The c.82+5G.A mutation in highlighted in bold. Lowercase letters indicate intronic
sequences and uppercase letters indicate exonic sequences. Lower panel: Sequencing analysis of a PCR product encompassing the exon1-intron 1
and exon 2 of NPC2 gene showed the presence of the c.82+5G.A mutation in homozygosis in cat 1. The mother carries the same mutation in
heterozygosis. C) Upper panel: schematic representation of the 59region of NPC2 gene. In the presence of the c.82+5G.A mutation a new 59donor
splice site located 105 bp downstream of the canonic donor splice site of intron 1 is activated. Lower panel: RT-PCR analysis of NPC2 mRNA in cat’s
fibroblasts. A fragment retaining 105 bp of intron 1 is detected in fibroblasts from cat 1. D) Western blot analysis of NPC2 protein isolated from cat’s
fibroblasts. A protein of a higher molecular weight is detected in fibroblasts from cat 1.
doi:10.1371/journal.pone.0112503.g001
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were routinely processed for histology and sections were stained
with haematoxylin and eosin (HE), periodic acid-Schiff (PAS),
Luxol fast blue (LFB), crystal violet for Nissl substance, and
Bielschowsky silver stain. Selected brain sections were stained with
the peroxidase-anti-peroxidase (PAP) method using a polyclonal
antibody against glial fibrillary acidic protein (GFAP; 1:1000,
Dako, Carpinteria, USA), CD3 (1:100, Dako, Carpinteria, USA),
ubiquitin (1:1000, Dako, Carpinteria, USA) and calbindin (1:299,
Santa Cruz Biotechnology, USA).
Results
Clinical findings
Two kittens (1 male and 1 female) from a litter of 5 were
evaluated for progressive neurologic signs. In both cats clinical
signs had an insidious onset at around 3 month of age,
characterized by intention tremors and truncal ataxia. Neurolog-
ical manifestations, suggestive of a cerebellar involvement, had a
slow progression and led to dystonia and worsening of gait over
time. At 6 months of age the female (cat 1) had a prayer-like
posture and was still ambulatory with hypermetria of the hind
limbs, while the male (cat 2) wasn’t able to stand without assistance
and had bilaterally reduced menace response. Cat 1 underwent a
complete diagnostic work-up and was clinically monitored during
the course of the disease. At 5 months of age an abdominal
ultrasonography was unremarkable, a complete blood cell count,
serum biochemistry panel (Table 1) and urine analysis showed
only a mild increase in ALT (51 U/l; normal values 5–45 U/l)
and CK (123 U/l; normal values 10–100 U/l). A titre of 1:1024
for anti-Toxoplasma gondii IgG was also found. The ALT values
at 7 and 19 months were 102 and 42 U/l, respectively. At 6
months of age the results of a magnetic resonance (MR) of the
brain were unremarkable, while the brainstem auditory evoked
potentials (BAEPs) showed a prolonged I–V interpeak latency.
Cat 2 died at the age of 10 months for respiratory paralysis. The
brain and spinal cord and samples of major organs were collected.
At 9 months cat 1 was unable to walk and developed seizures. It
was humanely euthanized a year later upon request of the owner
after developing severe dysphagia for the poor prognosis. Neither
of the cats showed clinical signs of pulmonary disease over the
course of their life, and serial clinical evaluations of respiratory
function revealed no obvious abnormalities
Biochemical and genetic analysis
Filipin staining of cultured fibroblasts from cat 1 showed
massive perinuclear storage of unesterified cholesterol which is
consistent with the biochemical phenotype of NPC disease
(Figure 1A). Molecular analysis of NPC1 and NPC2 genes was
then performed. No mutations were found in the NPC1 gene,
while NPC2 analysis showed the presence of an homozygous
intronic mutation located 5 nt downstream of the canonical donor
splice site of exon 1 (c.82+5G.A) (Figure 1B).
The possible effect of this mutation on the mRNA splicing
process was evaluated by RT-PCR and sequencing of the NPC2
mRNA. As shown in figure 1C, the mutation affects the splicing
process causing the retention of 105 bp of intron 1 in the mature
Figure 2. NPC2 protein alignments and structural analysis. A) Multiple NPC2 protein alignment among different mammalian orthologs The
cysteine residues have been marked with asterisks while residues in the prolin-rich region have been underlined. B) Structure of bNPC2. The bNPC2
crystal structure (PDB ID 2HKA) is shown in ribbons with the amino acid residues at the boundary of the insertion site shown in red in stick
representation (Gly28 and Ser29). A space-filling model of cholesterol has been bound in the proposed sterol-binding site. The cysteine residues
involved in the Cys27-Cys140 disulfide bound are represneted as orange sticks. Amino acid residue numbers are calculated considering aminoacid 1,
the first Metionine, as done in patient genotyping.
doi:10.1371/journal.pone.0112503.g002
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mRNA, which would lead to the in frame insertion of 35 amino
acids between residues 28 and 29 of the NPC2 protein
(p.G28_S29ins35). In addition, a small amount of normal spliced
mRNA was detected.
Western blot analysis showed the expression of an NPC2
immunoreactive protein with a higher molecular weight than the
protein expressed in normal fibroblasts, consistent with the
presence of a protein carrying the insertion of 35 amino acids
(Figure 1D).
Multiple sequence alignment of mutant NPC2 protein with wild
type feline, murine, human and bovine NPC2 showed that the
primary sequence is highly conserved among many mammalian
orthologs (Figure 2A). Indeed, human, bovine, murine and feline
proteins have 60% identity and 27% similarity. All polypeptide
sequences contain six cysteine residues, a proline-rich region
(PVPFPIP) and a variable number putative Asn-linked glycosyl-
ation.
To shed further light on the possible consequences of these
aminoacid changes at protein level, we performed a structural
protein analysis based on the 3D model of the protein.
The 3D structure of bovine NPC2 protein and its complex with
a cholesterol analog have been previously determined [20], [21]. It
consists of seven b-strands arranged in two b-sheets, related by a
30u rotation. Its structure has revealed a pocket and two cavities
that make a tunnel which widens to accommodate the substrate
[20], [21] (Figure 2B). Three disulfide bonds connecting residues
Figure 3. Post mortem histological analysis of central nervous system tissues. A) Brain stem: Cytoplasmic swelling of neurons with
accumulation of faintly eosinophilic storage material. H&E,6320. B) Cerebellar cortex: Spheroids within the granule cell layer are labelled with anti-
ubiquitin antibody. IHC,6125. C) Thalamus: Inflammatory infiltrate with perivascular lymphocytic cuffing. IHC for CD3,6200. D) Thalamus: Rod-
shaped activated microglial cells (arrows) are intermingled with enlarged neural cells. H&E,6400. E) Cerebellum: Marked loss of Purkinje cells and
dendrites is evidenced by calbindin immunostaining. IHC for calbindin,650. F) Cerebellar cortex: Loss of Purkinje cells is accompanied by gliosis in
the molecular layer. IHC for GFAP,6320. G) Thalamus: Storage material within ballooned neural cells is negative with PAS reaction. PAS,6200. H)
Brain stem: Intracytoplasmic storage material is negative with LFB staining. LFB,6400.
doi:10.1371/journal.pone.0112503.g003
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C27-C140, C42-C47 and C93-C99 stabilize the bNPC2 structure
[20]. G28-S29 amino acid residues lay on protein surface. Even
though the mutation does not appear to affect the cholesterol
binding site, the in frame insertion might alter the conformation of
the cholesterol binding pocket, since this pocket needs to expand in
order to accommodate cholesterol.
In addition, DiANNA software (http://clavius.bc.edu/,clotelab/
DiANNA/) was used to in silico analyze whether the mutated N-
terminus would change disulfide bond patterns within NPC2. It
was predicted that whereas residue 27 would bind with residue
140 in the wild type protein (score of 0.95678 on a scale of 0 to 1),
residue 27 would likely bind with residue 40 in the mutated
protein (score of 0.99751), which is located within the insertion.
The mutation is not predicted to alter the disulfide bonds C42-
C47, and C93-C99. This change may lead to protein instability.
Considering this scenario it is likely that the mutated protein is
partially degraded, consistent with the low levels of protein
expression detected by western blot.
Histological analysis
Post-mortem histological examination of cat 2 revealed a diffuse
storage process in neural and extraneural tissues. The brain was
macroscopically unaltered and showed diffuse neuronal ballooning
(Figure 3A) with Nissl substance and nuclei displacement,
associated with moderate gliosis. Moderate axonal fragmentation,
associated with a mild reduction of myelin staining with LFB, was
observed in the subcortical and cerebellar white matter. Spheroids
with accumulation of ubiquitinated aggregates were prominent in
the cerebellar cortex (Figure 3B). Scattered perivascular aggre-
gates of T lymphocytes (Figure 3C) accompanied by microglial
cells proliferation were present in the thalamus and midbrain
(Figure 3D). In the cerebellar cortex, Purkinje cells were markedly
reduced in number (Figure 3E) and the remaining cells showed
prominent intracytoplasmic storage. Proliferation of Bergmann
glia expressing GFAP was also observed (Figure 3F). The vascular
endothelium of the CNS showed no signs of storage. In all tissues,
the storage material was faintly eosinophilic and did not stain with
PAS (Figure 3G) and LFB (Figure 3H).
Histological examination of the liver showed the presence of
swollen hepatocytes because of accumulation of small vacuoles of
relatively uniform size, imparting foaminess to the cytoplasm
(Figure 4A). Dispersed small foamy Kupffer cells and congestion of
sinusoids were also detected. In the lungs, foamy macrophages
were observed within the pulmonary interstitium and alveoli
(Figure 4B). Pneumocytes and ciliated epithelial cells within
airway walls appeared morphologically normal.
Discussion
Niemann pick type C disease is a rare neurovisceral lysosomal
storage disorder caused by mutations in either NPC1 or NPC2
genes. Most human patients present mutations in NPC1 gene,
while only 5% of patients present mutations in NPC2 gene. In
humans, approximately 360 NPC1 and 22 NPC2 mutations have
been described to date.
NPC1 but not NPC2 spontaneous mutations have been
reported in different species other than humans, such us mouse,
cats and dogs [11], [12], [14], [15].
The clinical features of the 2 kittens described in this report
closely resemble the human NPC phenotype. The age at onset and
the progression of neurological symptoms were very similar to
those described in the feline model of NPC presenting mutations
in NPC1 gene [16], which resembles the juvenile form of the
disease in humans [22].
Neither of the cats presented hepatosplenomegaly or pulmonary
involvement. Although these two features are frequently present in
NPC patients, they are absent in half of the patients reported to be
affected by the juvenile/adult form of NPC2 [23], [24]. This
observation further support the idea that these cats would
resemble the juvenile phenotype of the human disease.
It is worth noting that the severe neonatal form of the disease is
the most common one among human NPC2 patients, while NPC2
mutations have been described only in few juvenile/adult patients
[23], [24], [25], [26].
Molecular analysis of the NPC2 gene led to the identification of
a homozygous intronic mutation located 5 nt downstream of the
canonical donor splice site of exon 1 (c.82+5G.A). Interestingly, a
mutation affecting the same splice site (c.82+2T.C) has been
described in a human patient [8]. However, although both
mutations affect the NPC2 mRNA splicing process, they lead to
the transcription of different splice variants. The c.82+2T.C
mutation leads to the synthesis of 3 splice variant of which one
retains 57 bp on intron 1 and would generate a protein with an in-
frame insertion of 19 aminoacids between 28 and 29 of the NPC2
protein (p.G28_S29ins19). Nevertheless, no NPC2 protein was
detected in cells carrying this mutation.
Instead, the c.82+5G.A mutation leads to the transcription of
one spliced variant retaining 105 bp of intron 1 in the mature
mRNA, which would lead to the in frame insertion of 35 amino
acids between residues 28 and 29 of the NPC2 protein
(p.G28_S29ins35). In addition, a small amount of normal spliced
mRNA was transcribed as well. However, only the aberrant
NPC2 mRNA variant carrying the 105 bp insertion seems to be
translated into NPC2 immunoreactive protein. It is likely that the
Figure 4. Post mortem histological analysis of liver and lung tissues. A) Liver: Hepatocytes have a foamy, vacuolated appearance due to
lipidstorage. H&E,6400. B) Lung: Accumulation of foamy macrophages accompanied by congestion and edema. H&E,6400.
doi:10.1371/journal.pone.0112503.g004
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amount of normal NPC2 mRNA expressed by these cells is too
low to generate enough wild type protein to be detected by western
blot analysis. It is worth noting that the clinical phenotype
displayed by these kittens suggests the presence of some residual
NPC2 function. In fact, cat 2 survived 10 months and cat 1 died at
21 months. However, whether the protein carrying an insertion of
35 aminoacids is also partially functional needs to be further
investigated.
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